JANX — Janux Therapeutics Share News
0.000.00%
Last trade - 00:00- $1.04bn
- $72.08m
- $10.00m
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Cloudflare, Boeing
Janux dives as gaps in prostate cancer study data worry investors
U.S. STOCKS ON THE MOVE-Janux Therapeutics, Bunge Global, Shopify
U.S. STOCKS ON THE MOVE-NIO, Warner Bros Discovery, gold miners
Janux plunges after early-stage data for prostate cancer drug
Janux Therapeutics Q3 net loss narrows, R&D expenses rise
Brief: Janux Therapeutics Q3 Basic EPS USD -0.39
Janux Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Janux Therapeutics Q2 Basic EPS USD -0.55
Janux Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Janux Therapeutics Q1 Basic EPS USD -0.38
Janux Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Janux Therapeutics Q4 Basic EPS USD -0.36
Brief: Janux Therapeutics Closes Public Offering For Proceeds Of $402.5 Mln
U.S. STOCKS ON THE MOVE-Uber, Tesla, LendingTree
Janux Therapeutics notches fresh record after $350 mln equity raise
Brief: Janux Therapeutics Announces Pricing Of $350.0 Million Underwritten Public Offering Of Common Stock
Brief: Janux Therapeutics Announces Proposed Public Offering
U.S. STOCKS ON THE MOVE-PSQ Holdings, Core Scientific, Keros